MENLO PARK, Calif., Sept. 24 /PRNewswire/ -- VasoNova (VasoNova Inc., Menlo Park, California) announced a strategic partnership with Navilyst Medical Inc. (Navilyst Medical Inc., Marlborough, Massachusetts) today to distribute its VasoNovaVascular Positioning System VPS central venous catheter navigation technology.
Commenting on the partnership, Navilyst Senior Vice President, George Bournesaid “Navilyst Medical is a market and technology leader in vascular access and fluid management with a long tradition of therapeutic innovation. Accurate catheter tip location is clinically beneficial to the patient and directly contributes to lowering healthcare costs. These two things are firmly aligned with our mission and reflected in our many other market leading innovations in vascular access. We are very excited to be bringing the VasoNova VPS catheter navigation technology to our customers. The combination of best-in-class central venous catheters from Navilyst and real time catheter tip positioning of this caliber from VasoNova provides the best possible solution to our clinicians and for our patients”.
Paul Molloy, President & Chief Executive Officer at VasoNova added, “VasoNova’s VPS technology is the first real-time intra-vascular catheter navigation technology that does not require external metal detectors or viewing screens, nor subjective interpretation of ECG signals, and is capable of confirming precise catheter tip location using highly sophisticated anatomical location identification algorithms embedded in its technology. These location signatures are identified utilizing highly specific Doppler ultrasound characteristics combined with other patient data. The VasoNovaVPS is compatible with all commonly used PICC and CVC catheters. Navilyst’s world-class vascular access product offering is highly synergistic and together we offer clinicians unparalleled technological advantages”.
VasoNova is a privately held company, founded in 2005 and has developed a completely unique central venous catheter navigation technology that allows real-time accurate confirmation of placement of PICC and CVC catheters in the lower one third of the superior vena cava, the optimal position for catheter tip location. More than ten million such catheters are placed in the United States each year.
Related link for more information: www.vasonova.com; www.navilyst.com
SOURCE VasoNova Inc.
